Treatment Adherence and Satisfaction in Multiple Sclerosis Patients from Upper Egypt

Multiple sclerosis (MS) is one of the most common disabling autoimmune disorders of the central nervous system. It affects up to 2.22 million young and middle-aged adults worldwide, leading to disability and loss of productivity. Although there is no cure for MS, marked evolution has been made in the disease modifying treatments (DMTs) that can alter the disease course. With increased number of available DMTs of different mechanisms of action, the aim of treatment was shifted from just reducing relapse rates and slowing the progression to preventing any symptoms of new disease activity. However, non- Adherence to DMTs is a major problem as in other chronic disorders, adding more to the morbidity, mortality, and health care costs related to multiple sclerosis. Therefore, particularly for populations with limited resources, early identification and management of factors leading to non-adherence to DMTsis wise strategy that will be reflected on patients, their families and society.